Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for…
Roche announced that the European Commission has granted a marketing authorisation for Ronapreve (casirivimab and imdevimab), for treating COVID-19 in adults and adolescents (from 12…
Read More...
Read More...
